What's stopping girls from getting the HPV jab?
The controversial HPV vaccine has been making only slow progress in the U.S. Despite the fact that half of all girls are exposed to the virus--and 4,000 die each year from the cancer that it triggers--only about twenty percent of the target population has been vaccinated.
There's been an intense debate over parents' reluctance to pay the $360 cost, concerns related to providing a vaccine that is associated with sexual activity on the part of their daughters and fear that the new vaccine could present unexpected side effects. Slate covered the pros and cons in an article that also underscored that new studies continue to report that the vaccine is safe.
- read the report from the Wall Street Journal
ALSO: Officials in New Zealand say that allergic reactions to the HPV vaccine have been very rare. Report
Related Articles:
Gardasil "remarkably safe," despite anaphylaxis
Is Gardasil worth the cost?
Gardasil side effects prompt CDC study
CDC details side effects reported on Gardasil
Comments
It will never cease to amaze me that there are more horses asses in this world than there are horses. How gullible is the public? Strange beliefs surface regarding all drugs. Stupid people dream them up and some who are more stupid believe them. The best one is, "Doctors do not want to cure cancer because they make a lot of money treating it." Doesn't anyone understand doctors and their families also develop cancer? Also, if they keep you alive from cancer they will get you for something else and can make a hell of a lot more money.
It will never cease to amaze me that there are more horses asses in this world than there are horses. How gullible is the public? Strange beliefs surface regarding all drugs. Stupid people dream them up and some who are more stupid believe them. The best one is, "Doctors do not want to cure cancer because they make a lot of money treating it." Doesn't anyone understand doctors and their families also develop cancer? Also, if they keep you alive from cancer they will get you for something else and can make a hell of a lot more money.
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


